BLACK FRIDAY SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim→
logo
Market statusData NSENot investment advice
YATHARTH HOSP & TRA C S L

YATHARTH HOSP & TRA C S L Latest Share Price (YATHARTH)

NSE: YATHARTHBSE 543950HealthcareHospitalwww.yatharthhospitals.com
₹1,093.25
14.75+1.37%
Overall Score56/100
Day range1,077
₹1,093.25
1,113
52-week538
₹1,093.25
1,184
Above low+103.1%
Below high7.7%
Range position86%
Open1,078.00
Prev Close1,078.50
Bid1,093.20100
Ask1,093.30100

TODAY IN ONE LINE

YATHARTH rose 1.4% on average volume, in line with Nifty's 1.1% move.

With a market cap of ₹10,492.99 Cr., it trades at a P/E of 55.90. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume237.7K−25%vs 20D avg
Price Band20
Lower Band776.8
Upper Band1,165.2
Tick Size0.05
Daily Volatility2.42%
Annualised Vol46.23%
Market Cap₹10,492.99 Cr.
Promoter55.8%
Face Value₹10
Fwd P/E26.85
PEG1.12
EV/EBITDA18.26
P/S6.42
ROA7.17%
Beta0.99
Div Payout—
THE STOCK SCORE
Overall Score56/100
Updated 07 Sept

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

YATHARTH HOSP & TRA C S L flags & news 

Key strengths, potential risks, and recent updates.

✅ 6 green flags🚩 1 red flag

Green Flags

  • ●Earnings GrowthEPS (TTM) grew by a solid 12.9% YoY
  • ●Healthy Operating MarginsOPM is structurally strong at 19.1%
  • ●High Promoter HoldingPromoters hold 55.8% skin-in-the-game
  • ●Virtually Debt-FreeVery low Debt-to-Equity of 0.14x
  • ●FII AccumulationFII holding increased by 1.43% QoQ
  • ●Zero Pledge RiskNo recent active promoter pledging found

Red Flags

  • ●Poor Capital ReturnsLow ROE of 9.4%

Latest YATHARTH HOSP & TRA C S L News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

No recent changes found for this period.
🔒Prime: full history + alerts on this stock
Valuation

YATHARTH HOSP & TRA C S L valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for YATHARTH HOSP & TRA C S L, framed against the sector median so the premium or discount is obvious at a glance.

YATHARTH HOSP & TRA C S L trades at a P/E of 55.90× and P/B of 5.59×.

Key MetricsMarket + reported · 20 Nov 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹10,492.99 Cr.
P/E Ratio
55.9
P/B Ratio
5.59
EPS
₹5.25
Profitability

Profitability

ROE
9.42%
ROCE
9.53%
Net Margin
14.69%
Op Margin
19.06%
Growth

Growth

EPS YoY
12.9%
Revenue YoY
44.2%
Qtr Sales
9.87%
Qtr Profit
6.68%
Financial Health

Financial Health

Debt / Equity
0.14
Book Value
₹187.55
Div Yield
0.05%
Promoter Holding
55.8%
Technicals

YATHARTH HOSP & TRA C S L technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for YATHARTH HOSP & TRA C S L — derived from the latest tape, not yesterday's close.

YATHARTH HOSP & TRA C S L last traded at ₹1,093.25 with an intraday range of ₹1,077.2–₹1,113.4 — latest indicator, pivot and CPR signals below.

Last updated: 22 November 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹1093.25
LevelPrice (₹)Distance% Δ
R41184.43+91.18+8.34%
R31148.23+54.98+5.03%
R21130.82+37.57+3.44%
R11112.03+18.78+1.72%
PIVOT1094.621.370.13%
CURRENT1093.25——
S11075.83-17.42-1.59%
S21058.42-34.83-3.19%
S31039.63-53.62-4.90%
S41003.43-89.82-8.22%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 1093.93P: 1094.62TC: 1095.30
R1
R2
R3
R4
indicator
LTP: 1093.25
PDH: 1101.75
PDL: 1071.75
● Market Sentiment

YATHARTH is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Narrower, suggesting likely for trending moves

● Opening Range

Day's range: ₹1077.2–₹1103.75

● Price Position

Trading Inside opening range

Financials

YATHARTH HOSP & TRA C S L financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for YATHARTH HOSP & TRA C S L — consolidated or standalone — with margins, YoY growth and key ratios inline.

YATHARTH HOSP & TRA C S L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹10,492.99 Cr. and reported EPS of ₹5.25.

iTap any row for a plain-English meaning▲▼Change vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
Mobile view
Latest vs previous year
MetricMar 2026May 2026
Revenue from Operations1,207
1,207
▲ 0.0%
Sales Growth YoY %Derived37.10%
37.10%
Other Income26
26
▲ 0.0%
Total Income1,233
1,233
▲ 0.0%
235
235
▲ 0.0%
Gross ProfitDerived973
973
▲ 0.0%
Gross Margin %Derived80.57%
80.57%
681
681
▲ 0.0%
EBITDA (Operating Profit)Derived292
292
▲ 0.0%
OPM %Derived24.20%
24.20%
94
94
▲ 0.0%
Profit Before Tax (PBT)224
224
▲ 0.0%
53
53
▲ 0.0%
Effective Tax %Derived23.82%
23.82%
Total Profit for Period170
170
▲ 0.0%
Net Profit (Owner's PAT)Derived170
170
▲ 0.0%
Net Profit Margin %Derived14.11%
14.11%
PAT Growth YoY %Derived30.45%
30.45%
Earnings Per Share (EPS ₹)17.67
17.67
▲ 0.0%
Diluted Shares Outstanding (Cr)10
10
▲ 0.0%
Other Comprehensive Income (Net of Tax)1
1
▲ 0.0%
Total Expenses (incl. D&A & Interest)1,009
1,009
▲ 0.0%
Material Cost % of RevenueDerived—
—
Employee Cost % of RevenueDerived19.43%
19.43%
Other Cost % of RevenueDerived36.94%
36.94%
Interest Coverage (x)Derived31.26x
31.26x
Sales CAGR · 3Y
+11.1%
Sales CAGR · 5Y
+12.5%
PAT CAGR · 3Y
+9.3%
PAT CAGR · 5Y
+8.3%
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

YATHARTH HOSP & TRA C S L segment analysis : revenue and profit mix.

Disclosed business segments at YATHARTH HOSP & TRA C S L with their share of revenue and profit, switchable between consolidated and standalone reporting.

YATHARTH HOSP & TRA C S L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for YATHARTH HOSP & TRA C S L.

Our AI distills the core fundamental drivers supporting YATHARTH HOSP & TRA C S L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

Key Risks.

No weaknesses or threats on record.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 73 would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.

  • Return-quality risk. ROE below 8% would indicate weaker capital compounding.

Shareholding

YATHARTH HOSP & TRA C S L shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in YATHARTH HOSP & TRA C S L — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Annual • Sep 2026

Public26.21%↓1.53%
DII10.94%↑0.10%
FII7.05%↑1.43%
Promoters55.80%

Ownership Distribution

Retail & Public
26.21%
Domestic Institutions
10.94%
Foreign Institutions
7.05%
Promoters
55.80%

Category Trends

Foreign Institutions Breakdown
Total Holding: 7.05%
Net Change: +1.43%
Category Total7.05%
Total Holding7.05%
Net Change+1.43%
Not Fully Disclosed

⚠️Partial Disclosure Notice

Individual institutions below total 1.16%, but category aggregate is 7.05%. Some institutions may not be disclosed by the company as per regulatory requirements.

Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod
JUPITER INDIA FUND
1.16%
0.00%
0.00%
Sep 2026
THINK INDIA OPPORTUNITIES MASTER FUND LP
0.00%
0.00%
0.00%
Sep 2026
Peers

YATHARTH HOSP & TRA C S L peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — YATHARTH HOSP & TRA C S L is highlighted for quick read-across.

09 · Chart Patterns

YATHARTH HOSP & TRA C S L chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for YATHARTH HOSP & TRA C S L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

YATHARTH HOSP & TRA C S L delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for YATHARTH HOSP & TRA C S L over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in YATHARTH HOSP & TRA C S L stood at 40.8% of traded volume, against a 20-day average of 38.2%.

Avg Delivery (20D)38.2%+2.5 ppt latest vs avg
Highest Delivery47.6%on 12 Nov
Avg Volume (20D)3.17 L20-day run-rate
Conviction Trend↓ Weakening+2.5 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

YATHARTH HOSP & TRA C S L announcements: results, concalls, ratings, M&A.

Filings YATHARTH HOSP & TRA C S L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

YATHARTH HOSP & TRA C S L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 172 documents below.

  1. 12 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    We hereby submit Earnings Call Transcript Q2FY27.

  2. 12 Nov 2026General UpdatesView PDF

    General Updates

    We hereby submit intimation regarding the Approval of CCI for the proposed Preferential Issue.

  3. 05 Nov 2026Monitoring Agency ReportView PDF

    Monitoring Agency Report

    We hereby submit Monitoring Agency Report for the quarter ended September 30, 2026 (IPO).

  4. 04 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    We hereby submit Earnings Call Recording for Q2FY27.

  5. 04 Nov 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    We hereby submit Newspaper Publication of Unaudited Financial Results - Q2FY27.

Corporate Actions

YATHARTH HOSP & TRA C S L dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue YATHARTH HOSP & TRA C S L has declared, sequenced by announce and record date.

YATHARTH HOSP & TRA C S L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About YATHARTH HOSP & TRA C S L: business, sector, key facts.

What YATHARTH HOSP & TRA C S L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

YATHARTH HOSP & TRA C S L operates in the Hospital industry under the Healthcare sector, listed as NSE: YATHARTH, BSE: 543950.

YATHARTH
Healthcare

YATHARTH HOSP & TRA C S L

NSE · YATHARTH·BSE · 543950·www.yatharthhospitals.com

Yatharth Hospital & Trauma Care Services Limited is a healthcare provider operating multi-specialty hospitals in Delhi and Madhya Pradesh, India. The company's core business revolves around providing a wide range of medical services across numerous specialties, aiming to offer comprehensive care under one roof. Established in 2008 and based in Noida, the company has grown to encompass a substantial network of healthcare facilities.

Their services cover a vast spectrum of medical disciplines. This includes critical care, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics and spine surgery, rheumatology, plastic and cosmetic surgery, ENT, endocrinology, dermatology, nuclear medicine, oncology (including cancer and bone marrow transplant), gastrointestinal surgery and liver transplant, robotic surgery, IVF and fertility treatments, ophthalmology, dentistry, psychology and psychiatry, physiotherapy and rehabilitation, anesthesiology, radiology, pathology and laboratory medicine, and interventional spine and pain medicine. The breadth of specialties offered positions Yatharth as a significant player in the Indian healthcare market.

Beyond direct medical services, Yatharth also engages in ancillary businesses to support its hospital operations. These include the sale of medicines within their facilities and the operation of hospital canteens, providing convenient access to essential products and services for patients and staff. These secondary revenue streams contribute to the overall financial health of the company and enhance the patient experience.

In summary, Yatharth’s business model centers on providing high-quality, comprehensive healthcare services across a wide array of specializations. The company’s integrated approach, incorporating both core medical services and ancillary businesses, positions it to cater to a broad range of patient needs and contribute to the overall health and well-being of the communities it serves within India.

company facts
Employees—
SectorHealthcare
HeadquartersNoida, India
Market Cap₹10,492.99 Cr.
Listed OnNSE
leadership24 on record
Dr. Ajay Kumar Tyagi
Chairman
Dr. Ajay Kumar Tyagi
Chairman & Whole-time Director
Dr. Ajay Tyagi
Executive Chairman of the Board, Whole Time Director
Dr. Anil Kumar Kumaoni
Chief Operating Officer
Dr. Kapil Kumar
Managing Director
Dr. Kapil Kumar Tyagi
MD & Director
Dr. Sanjeev Upadhyaya
Non-Executive Independent Director
Mr. Amit Kumar Singh
Group Chief Executive Officer
Mr. Amit Singh
Group Chief Executive Officer
Mr. Ashutosh Kumar Jha
Group Chief Strategy, M&A & Investor Relations
Mr. Deepak Kumar Tyagi
President of Strategy and Finance
Mr. Mukesh Sharma
Non-Executive Independent Director
§ ∞ · Plainly Answered

Questions investors ask about YATHARTH HOSP & TRA C S L (YATHARTH).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of YATHARTH HOSP & TRA C S L (YATHARTH)?

The current share price of YATHARTH HOSP & TRA C S L (YATHARTH) is ₹1,093.25. Today, the stock has gained by ₹14.75 (1.37%), trading in a range of ₹1,077.20 to ₹1,113.40. The stock opened at ₹1,078.00 with a trading volume of 2,37,743 shares.

02Is YATHARTH HOSP & TRA C S L stock a good investment for long-term?

YATHARTH HOSP & TRA C S L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹10,492.99 Cr., P/E ratio of 55.9, ROE of 9.42%, and ROCE of 9.53%. The dividend yield stands at 0.05%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of YATHARTH HOSP & TRA C S L stock?

The 52-week high price of YATHARTH HOSP & TRA C S L (YATHARTH) is ₹1,184.00, while the 52-week low is ₹538.25. Currently trading at ₹1,093.25, the stock is 103.11% above its 52-week low and 7.66% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy YATHARTH HOSP & TRA C S L stock at the current price?

Whether to buy YATHARTH HOSP & TRA C S L stock at ₹1,093.25 depends on multiple factors. The stock is currently trading with a P/E ratio of 55.9 and P/B ratio of 5.59. Today's performance shows a gain of 1.37%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of YATHARTH HOSP & TRA C S L and when is the next dividend?

YATHARTH HOSP & TRA C S L offers a dividend yield of 0.05%, which means for every ₹100 invested at the current price of ₹1,093.25, you can expect to receive approximately ₹0.05 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of YATHARTH HOSP & TRA C S L?

YATHARTH HOSP & TRA C S L's key financial metrics include: P/E Ratio: 55.9, P/B Ratio: 5.59, ROE: 9.42%, ROCE: 9.53%, Dividend Yield: 0.05%, EPS: ₹5.25, Book Value: ₹187.55, and Debt-to-Equity: 0.14. The company's market cap stands at ₹10,492.99 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is YATHARTH HOSP & TRA C S L stock performing today in the market?

YATHARTH HOSP & TRA C S L stock opened at ₹1,078.00 and is currently trading at ₹1,093.25, showing a gain of ₹14.75 (1.37%). The intraday high is ₹1,113.40 and low is ₹1,077.20. The trading volume stands at 2,37,743 shares, indicating moderate market participation today.

08What is the P/E ratio of YATHARTH HOSP & TRA C S L and what does it indicate?

YATHARTH HOSP & TRA C S L has a Price-to-Earnings (P/E) ratio of 55.9, which means investors are willing to pay 55.90 for every ₹1 of earnings. With an EPS of ₹5.25, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about YATHARTH HOSP & TRA C S L (YATHARTH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.